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Abstract Platelet-activating factor (PAF) is a potent phospho-
lipid mediator which binds to a specific, high affinity receptor of 
the G protein-coupled receptor family. In the present report, we 
show that ligand binding to the PAF receptor is sensitive to the 
reducing agent dithiothreitol (DTT), suggesting the involvement 
of disulfide linkages in the proper PAF receptor conformation. 
Substitutions of Cys90, Cys* and Cys1" to Ala or Ser 
demonstrated that these cysteine residues are critical for normal 
cell surface expression of the PAF receptor protein and ligand 
binding to the receptor. The Cys90 and Cys17' mutant receptors 
did not display any specific ligand binding, were not expressed on 
the cell surface but were found in the intracellular compartment. 
The Cys95 mutants showed specific binding and were able to 
stimulate low levels of inositol phosphate (IP) production. These 
mutants were expressed at low density on the cell surface and 
showed high expression intracellularly. Our results suggest that 
the structure and function of the PAF receptor require the 
conserved Cys90 and Cys173 to form a disulfide bond. Moreover, 
Cys95 also appears to be necessary, possibly by establishing a 
disulfide linkage with an as yet unidentified Cys residue. All three 
residues appear essential for the proper folding and surface 
expression of the PAF receptor protein. 
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1. Introduction 
Seven transmembrane-spanning, guanine nucleotide-bind-
ing (G) protein-coupled receptors (GPCRs) constitute a large 
family of cell surface regulatory molecules. Because of the 
evidence that has accumulated to implicate disulfide and thiol 
groups in ligand binding and agonist activation, cysteine res-
idues have been the subject of considerable investigation using 
mutagenesis and biochemical techniques. The majority of 
GPCRs sequenced to date contain a pair of conserved Cys 
residues in the second and third extracellular domains. It has 
been assumed that this pair of Cys residues forms a disulfide 
bond in most GPCRs. This linkage has been proposed to be 
important to allow the receptor to attain a normal conforma-
tion during synthesis, for proper cell surface expression and 
function, in particular, binding and activation [1]. For some 
receptors of the GPCR family, data consistent with the pres-
ence of a disulfide bond between these two conserved Cys 
residues have been reported, but there is evidence that these 
conserved residues do not always participate in a disulfide 
linkage. For example, data from a series of ß2-adrenergic 
mutants show that there is no disulfide bond between the 
two conserved Cys [2]. 
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The PAF receptor is a member of the GPCR superfamily 
[3-7]. The human PAF receptor amino acid sequence contains 
twelve Cys residues. The two residues are found in the second 
(Cys90) and the third (Cys173) extracellular domains were pro-
posed to form disulfide bond, based on a molecular model of 
the receptor [8]. Another Cys residue (Cys95), found at the 
border of the second extracellular domain and the third trans-
membrane domain, could potentially be involved in the for-
mation of the disulfide linkage with Cys173, instead of Cys90. 
Therefore, site-directed mutagenesis and transient expression 
of PAF receptor mutants with Cys amino acid substitutions 
were used to identify the role of these three residues in the 
structure and function of the receptor and to verify which of 
the Cys90 or Cys95 residues was forming a disulfide bond with 
Cys173. 
2. Materials and methods 
2.1. Construction of the mutant receptor cDNAs and expression vectors 
Mutated receptors were constructed by polymerase chain reaction 
(PCR) [9] using the PAF receptor cDNA from Kpl32 as template (a 
generous gift from Dr. Richard Ye, The Scripps Research Institute, 
La Jolla, CA) [6]. Mutant oligonucleotides were as follows: C90A, 
5'-CCAAATTCCTGGCCAACGTGGC-3'; C90S, 5'-CCAAATTC-
CT-GTCCAACGTGGC-3'; C95A, 5'-GTGGCTCCCGCCCTTTTC-
T-TC-3'; C95S, 5'-TGGCTGGCAGCCTTTTC-3'; C173A, 
5'-GTCA-CTCGCGCCTTTGAGCATTAC-3'; C173S, 5'-CGTCA-
CTCGCTC-CTTTGAGC-3' and their respective reverse comple-
ments. The mutant PCR products were digested with BglH-BstEIT 
and subcloned into the pJ3M vector (kindly provided by Dr. J. Chern-
off, Fox Chase Cancer Center, Philadelphia, PA) [10] containing the 
WT receptor, in frame with the 'cmyc' epitope, also digested with 
Bgñl-BstEl\. The region corresponding to the subcloned PCR frag-
ments was sequenced on both strands by dideoxy sequencing of dou-
ble-stranded DNA with Sequenase (U.S. Biochemical Corp.). 
2.2. Cell culture and transfections 
COS-7 and CHO cells were grown in Dulbecco's modified Eagle's 
medium (high glucose) and Dulbecco's modified Eagle's medium F-12 
(Ham's medium, high glucose), respectively, supplemented with 10% 
fetal bovine serum. A stable line of CHO cells expressing WT PAF 
receptor [11] were cultivated in the presence of 400 |ig/ml of G418. 
Cells were plated in 30-mm dishes (2xl05 cells/dish), transiently 
transfected with the constructions encoding the WT and the mutant 
receptors using 4 ul of lipofectamine (Life Technologies, Inc.) and 1 ug 
of DNA per dish and harvested 48 h after transfection. 
2.3. Radioligand binding assay 
Competition binding studies were done on CHO cells expressing the 
wild-type and mutant receptor species. Cells were harvested and 
washed twice in HEPES-Tyrode's buffer (140 mM NaCl, 2.7 mM 
KC1, 1 mM CaCl2, 12 mM NaHCO;!, 5.6 mM D-glucose, 0.49 mM 
MgCl2, 0.37 mM NaH2P04, 25 mM HEPES pH 7.4) containing 0.1% 
(w/v) bovine serum albumin [12]. Binding reactions were carried out 
on 5 X 104 cells in a total volume of 0.25 ml in the same buffer with 
10 nM [3H]WEB2086 (Du Pont-New England Nuclear) and increasing 
concentrations of nonradioactive WEB2086 for 90 min at 25°C. Re-
actions were stopped by centrifugation. The cell-associated radioac-
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tivity was measured by liquid scintillation. Membrane fractions were 
prepared and binding carried out as previously described [11]. Binding 
reactions involving [3H]PAF (4 nM) were performed on intact adher-
ent CHO cells in a total volume of 600 |xl of binding buffer containing 
150 mM choline chloride, 10 mM Tris-HCl, 10 mM MgCl2, pH 7.5, 
and 0.25% lipid-free bovine serum albumin [13]. Samples were incu-
bated for 4 h at 4°C. Cells were washed twice with ice-cold buffer 
(1 ml), lysed with 0.1 N NaOH, and analyzed for radioactivity [13]. In 
selective experiments, cells were preincubated with DTT (10 mM) 
[l]±selenol (0.8 mM) (selenol was generated in situ from selenocyst-
amine, Sigma) [14] for 60 min at room temperature prior to perform-
ing binding reactions. DTT ± selenol was present at the same concen-
trations during the binding reactions. 
2.4. Inositol phosphate determination 
COS-7 cells were transfected as described above with the wild-type 
or mutant receptors and labeled the following day for 18-24 h with 
[3H]myo-inositol (Amersham) at 5 uCi/ml in Dulbecco's modified Ea-
gle's medium (high glucose, without inositol) (Life Technologies, Inc.). 
After labeling, cells were washed once in phosphate-buffered saline 
(PBS) and preincubated 5 min in PBS at 37°C. At the end of this 
preincubation period, the PBS was removed and cells were incubated 
in pre-warmed Dulbecco's modified Eagle's medium (high glucose, 
without inositol) containing 0.1% (w/v) bovine serum albumin and 
20 mM of LiCl, for 5 min. Cells were then stimulated for 30 s with 
indicated concentrations of PAF. The reactions were terminated with 
the addition of perchloric acid followed by a 30 min incubation on ice. 
Inositol phosphates (IPs) were extracted [15] and separated on Dowex 
AG1-X8 (Bio-Rad) columns [16]. Total labeled IPs were then counted 
by liquid scintillation. 
2.5. Flow cytometry studies 
CHO cells transfected with cmyc-tagged mutant and WT receptor 
constructions were harvested 48 h after transfection and subjected to 
flow cytometry analysis. Cells (2.5 X 105) were washed twice in PBS 
and labeled with anti-cmyc antibody (9E10 hybridoma, ATCC) or 
with an isotype control antibody (anti-HA, epitope 12CA5 of influ-
enza hemagglutinin protein, Boehringer Mannheim) at room temper-
ature (RT) for 30 min. Cells were then washed with PBS and incu-
bated at RT for an additional 30 min with fluorescein isothiocyanate-
conjugated goat anti-mouse antibody (Bio/Can). All measures were 
performed on a FACScan flow cytometer (Becton-Dickinson). 
2.6. Confocal microscopy 
Transiently transfected CHO cells were grown on coverslips 
(25 mm). 48 h after transfection the cells were fixed with 4% para-
formaldehyde (15 min at RT). The coverslips were then placed in 0.1% 
Triton (20 min RT), then sequentially incubated with 5% milk (30 min 
RT) and 0.1% glycine (60 min RT). The cells were then incubated 
with anti-cmyc or isotype control antibodies as described for flow 
cytometry studies. The cells were then analyzed on a Molecular Dy-
namics (Sunnyvale, CA) Multi Probe 2001 confocal argon laser scan-
ning system equipped with a Nikon Diaphot epifluorescence inverted 
microscope. Scanned images were transferred onto a Silicon Graphics 
Indy 4000 workstation equipped with Molecular Dynamics' Image-
space analysis software. 
3. Results and discussion 
In order to study the role of Cys90, Cys95 and Cys173 resi-
dues in the structure and function of the human PAF recep-
tor, these Cys were individually altered to Ser and Ala using 
site-directed mutagenesis. The mutant receptors were transi-
ently expressed in COS-7 and CHO cells for evaluation of 
binding pharmacology and cell signaling. Fig. 1 illustrates 
the position of the mutated Cys relative to the overall molec-
ular structure of the PAF receptor. 
3.1. Effects of disulfide bond reduction on ligand binding 
Fig. 2A shows the effect of the reducing agent DTT on 
specific [3H]WEB2086 and [3H]PAF binding. Selenol has 
been reported to increase the rate of disulfide bond reduction 
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Fig. 1. Putative seven-transmembrane-segment topography of the 
PAF receptor. Solid circles indicate the amino acids of the PAF re-
ceptor that were mutated and the substituting residues are illus-
trated. 
by DTT [14]. In presence of DTT alone or with selenol, spe-
cific [3H]PAF binding to the WT receptor was only « 6 0 % 
and ~ 63% of that to the untreated receptors, respectively. In 
addition, similar effects were observed for the antagonist 
[3H]WEB2086 with =46% (DTT) and =42% (DTT+selenol) 
residual binding. These results suggest that disulfide bonds are 
required for proper binding of structurally distinct ligands of 
the PAF receptor. In these experiments, the addition of sele-
nol to the reaction did not potentiate the effect of DTT. In 
Fig. 2B,C, binding isotherms revealed no change in receptor 
affinity for [3H]WEB2086 or [3H]PAF when incubated with or 
without DTT ± selenol. This indicates that the binding sites 
observed after treatment were probably intact receptors. 
3.2. Analysis of the mutant receptor ligand binding and cell 
signaling 
Fig. 3A indicates the specific [3H]WEB2086 and [3H]PAF 
binding to the mutant and the WT receptors. Only the C95A 
and the C95S mutants displayed detectable specific binding, 
although too weak to be able to produce reliable equilibrium 
binding isotherms. The C90A, C90S, C173A and C173S mu-
tant-expressing cells did not show any specific binding for 
either ligand. Binding reactions carried out on crude mem-
brane preparations gave the same results (data not shown), 
suggesting that these mutations produce receptors incapable 
of binding their ligands. In order to determine whether the 
substitution mutant PAF receptors were appropriately 
coupled to signaling effector molecules, we measured the pro-
duction of IPs in transiently transfected COS-7 cells following 
a 30-s stimulation over a 0-10~6 M PAF concentration range. 
PAF concentrations higher than 10 - 6 M were not used as 
PAF has been shown to have non-receptor mediated effects 
at these concentrations [17]. Fig. 3B demonstrates that the 
WT receptor attained a maximal response at =10~ 7 M 
PAF and a half-maximal response at ~ 10~8 M PAF 
(IC50 = 10 nM). The C95A mutant receptor produced IPs fol-
lowing PAF stimulation, although its response curve was 
shifted to the right by 2 orders of magnitude, and did not 
reach a maximal response with the agonist concentrations 
used. The C95S mutant receptor displayed a subtle response 
only at 10~6 M PAF. As expected from the ligand binding 
results, the other mutants did not respond to PAF stimula-
tion. 
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Fig. 2. Effects of DTTtselenol. A: [3H]WEB2086 and [3H]PAF 
specific binding on CHO cells expressing the WT receptors. B: 
Competition binding isotherms of [3H]WEB2086 by WEB2086. C: 
Competition binding isotherms of [3H]PAF by PAF. The results are 
the means ± S.E.M. of three independent experiments, each done in 
triplicate. 
3.3. Determination of mutant PAF receptor cell surface 
expression 
The cmyc-tagged mutant and WT receptors were then an-
alyzed for cell surface expression by flow cytometry. Fig. 4 
illustrates that cells expressing the WT receptors showed 
25 ± 5% of specific fluorescence associated with the presence 
of PAF receptors at the cell surface, whereas cells expressing 
mutant receptors C95A and C95S showed 4% and 6%, over 
basal fluorescence, respectively. Cys90 and Cys173 mutant re-
ceptors were apparently not expressed on the cell surface as 
they were not detected by flow cytometry (data not shown). 
The possibility that the mutant receptors were produced but 
not expressed on the cell surface was examined using permea-
bilized cells and fluorescence microscopy. Fig. 5 shows that 
the WT PAF receptor is mostly found on the cell surface 
whereas the mutant receptors are all expressed and found in 
large quantity intracellularly. An isotype control antibody 
(WT-c) did not show any specific staining of wild type recep-
tor expressing cells. Similar results with the control antibody 
were obtained with all the transfectants (results not illus-
trated). 
Taken altogether, our results show that the Cys90, Cys95 
and Cys173 residues have profound effects on the structure-
function relationship of the PAF receptor. The fluorescence 
and binding studies suggest that these amino acids might be 
necessary for proper protein folding of the receptor molecule. 
We have demonstrated that normal cell surface expression 
and ligand binding require these three residues. Whether bind-
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Fig. 3. Specific binding and IP production by the Cys95 mutants. A: 
[3H]WEB2086 and [3H]PAF specific binding on COS-7 cells express-
ing the WT, C95A and C95S mutant receptors. Reactions were car-
ried out as described in Section 2. B: IP accumulation in response 
to graded concentrations of PAF. Total IPs were measured in COS-
7 cells transfected with vector alone (control), the WT or the mu-
tant receptors following a 30-s stimulation with the indicated PAF 
concentrations. The results are the means of three independent ex-
periments, each done in duplicate. 
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Fig. 4. Cytofluometry analysis of cmyc-tagged WT and Cys95 mutant receptors transiently transfected in CHO cells. Transiently transfected 
CHO cells expressing the cmyc-tagged WT and mutant receptors were stained with a control antibody (anti-HA) or specific anti-cmyc antibody 
followed by a fluorescein-conjugated secondary antibody. The cells were then analyzed on a flow cytometer (FACScan). The dot plots illustrate 
a representative experiment of cells transfected with the WT receptor, C95A or C95S. The numbers are means ± S.E.M. of the specific % of flu-
orescence obtained from six independent experiments. 
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Fig. 5. Fluorescent microscopy analysis of the WT and cysteine mutant receptors. Expression of WT and mutant PAF receptors was examined 
in transiently transfected CHO cells. The photographs show a representative cell stained with anti-cmyc antibody and a fluorescein conjugated 
secondary antibody. WT-c shows a cell transfected with the WT receptor but stained with anti-HA as primary antibody, white bar represents 1 
(im. 
ing experiments were performed on crude membrane prepara-
tions or whole cells did not affect the results. 
When either Cys90 or Cys173 were mutated to Ser or Ala, 
the resulting receptors were defective in ligand binding and 
were not detected on the cell surface. The C95A and C95S 
mutants displayed marginal ligand binding capability and 
some cell surface expression. Thus, it seems that the Cys90 
and Cys173 would be involved in forming a disulfide bond 
together, since mutants from either site displayed the same 
phenotype. Cysteines at these respective positions are widely 
conserved throughout the superfamily of GPCRs and are felt 
to constitute a structurally necessary disulfide bond between 
extracellular loops one and two [18]. It also appears that elim-
ination of this disulfide bond, by removing either of the two 
involved cysteines, destroys WEB2086 and PAF binding. 
These results would be in agreement with a recent molecular 
model of the PAF receptor [8]. Similar results were obtained 
on rhodopsin [19] with equivalent Cys (110 and 187) substi-
tution to Ser. Mutant rhodopsins did not bind 11-cw-retinal, 
and were processed and inserted into membranes at relatively 
low levels. It was concluded that in absence of this disulfide 
bond, rhodopsin does not undergo proper protein folding. 
Mutation of the analogous cysteines at positions 98 and 178 
of the Mi muscarinic receptor [20] and of cysteines 105 and 
183 of the thromboxane A2 receptor [18], like the PAF recep-
tor, resulted in a receptor with no binding or signaling capa-
bility. It is possible that the disulfide linkage may form during 
the early stages of receptor synthesis and be necessary for the 
normal folding and insertion into the membrane of these cell 
surface proteins. It has been shown that when participating 
cysteine residues are changed by mutagenesis, maturation and 
transport of the proteins from the ER are drastically reduced 
due to misfolding and aggregation [21]. This is supported by 
our data showing that the mutant receptors are produced 
abundantly but remain in the intracellular compartment. 
From the binding and IP production data, the C95S and 
the C95A mutant receptors seem to have a lower affinity for 
PAF and/or a lower coupling efficiency to signal transduction 
molecules than the WT receptor, in addition to the very low 
level of cell-surface expression. Due to the impossibility to 
obtain binding isotherms for these mutants, it is not possible 
to determine if one or both mechanisms are specifically in-
volved. The C95S and the C95A mutants also expressed dif-
ferent phenotypes, with the C95S receptor showing less spe-
cific ligand binding and a very subtle IP response to PAF 
stimulation in spite of an equivalent cell surface expression. 
Similarly, it was observed that substitution of Cys residues to 
Ser in rhodopsin resulted in more marked deleterious effects 
than substitution with Ala [22]. Our results suggest that Cys95 
may be involved in formation of a disulfide bond with another 
Cys residue of the PAF receptor important to the structure-
function relationship of the receptor, although less critical 
than the one possibly formed between Cys90 and Cys173. Al-
ternatively, mutation of Cys95 in itself may result in the phe-
notypes observed, suggesting a structural/functional role for a 
free sulfhydryl group of Cys95 in the PAF receptor. In fact, 
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data from alkylation studies have shown that free sulfhydryl 
groups were necessary for proper binding of P A F to its re-
ceptor [23]. 
In summary, the results of the present study demonstrate 
the involvement of disulfide linkages in the normal P A F re-
ceptor conformation. Moreover, we have shown that Cys90 
and Cys1 7 3 appear to form a disulfide bond critical to the 
structure and function of the P A F receptor. Cys9 5 is also 
determinant in the native P A F receptor conformation, possi-
bly by forming a disulfide bond with an amino acid of the 
receptor other than Cys1 7 3 , or by the requirement of its free 
sulfhydryl group. In the absence of these cysteines, the recep-
tor protein is produced but not exported efficiently to the cell-
surface membrane. 
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